XSHE002805
Market cap428mUSD
Jan 09, Last price
11.22CNY
1D
0.63%
1Q
-1.49%
Jan 2017
-53.00%
IPO
156.39%
Name
Shandong Fengyuan Chemical Co Ltd
Chart & Performance
Profile
Shandong Fengyuan Chemical Co., Ltd. develops, produces, and sells industrial oxalic acid, refined oxalic acid, and oxalate products in China and internationally. It also provides potassium tetroxalate, lithium iron phosphate, potassium binoxalate, sodium nitrate, and lithium cathode materials. The company's products are mainly used in pharmaceutical, rare earth, fine chemical, daily chemicals, textile printing and dyeing, and other industries, as well as biopharmaceutical, new energy vehicles, energy conservation and environmental protection, and various other fields. Shandong Fengyuan Chemical Co., Ltd. was founded in 2000 and is based in Zaozhuang, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 2,776,790 59.98% | 1,735,732 116.14% | |||||||
Cost of revenue | 3,055,343 | 1,451,377 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | (278,553) | 284,356 | |||||||
NOPBT Margin | 16.38% | ||||||||
Operating Taxes | (86,165) | 28,682 | |||||||
Tax Rate | 10.09% | ||||||||
NOPAT | (192,388) | 255,674 | |||||||
Net income | (389,318) -358.03% | 150,882 184.20% | |||||||
Dividends | (104,643) | (5,338) | |||||||
Dividend yield | 2.34% | 0.07% | |||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 1,378,635 | 615,679 | |||||||
Long-term debt | 1,075,474 | 754,046 | |||||||
Deferred revenue | 40,229 | 29,890 | |||||||
Other long-term liabilities | 1 | (753,575) | |||||||
Net debt | 1,747,715 | 625,869 | |||||||
Cash flow | |||||||||
Cash from operating activities | (1,488,110) | ||||||||
CAPEX | (431,416) | ||||||||
Cash from investing activities | (429,318) | ||||||||
Cash from financing activities | 1,612,464 | 3,112,897 | |||||||
FCF | (1,040,646) | (2,240,603) | |||||||
Balance | |||||||||
Cash | 684,004 | 743,856 | |||||||
Long term investments | 22,391 | ||||||||
Excess cash | 567,555 | 657,069 | |||||||
Stockholders' equity | 1,063,465 | 1,294,191 | |||||||
Invested Capital | 4,691,806 | 3,050,329 | |||||||
ROIC | 12.56% | ||||||||
ROCE | 6.37% | ||||||||
EV | |||||||||
Common stock shares outstanding | 280,085 | 257,641 | |||||||
Price | 15.98 -44.79% | 28.94 28.43% | |||||||
Market cap | 4,475,755 -39.98% | 7,456,867 46.91% | |||||||
EV | 6,919,648 | 8,682,373 | |||||||
EBITDA | (152,958) | 340,749 | |||||||
EV/EBITDA | 25.48 | ||||||||
Interest | 83,245 | 33,755 | |||||||
Interest/NOPBT | 11.87% |